Regulatory and catalytic domains of platelet cAMP phosphodiesterases: targets for drug design
Sheth, S.B.; Colman, R.W.
Seminars in Hematology 32(2): 110-119
1995
ISSN/ISBN: 0037-1963 PMID: 7652578 Document Number: 449792
Document emailed within 1 workday
Related Documents
Sadowski, I.; Pawson, T. 1987: Catalytic and non-catalytic domains of the Fujinami sarcoma virus P130gag-fps protein-tyrosine kinase distinguished by the expression of v-fps polypeptides in Escherichia coli Oncogene 1(2): 181-191Shi, T.-Y.; Deng, W.-Y.; Xie, J.-P. 2012: Regulatory mechanism underlying pathogen biofilm formation and potential drug targets Yao Xue Xue Bao 47(2): 135-143
Bolander, F.F. 2010: Intelligent design: drug targets for the prevention of osteoporosis Current Opinion in Investigational Drugs 11(4): 382-384
Rangel-Aldao, R.; Cayama, E.; Allende, O.; Triana, F. 1988: Isolation of a Trypanosoma cAMP-binding protein which is not a regulatory subunit of cAMP-dependent protein kinase Methods in Enzymology 159: 286-298
Stefanovich, V. 1975: Inhibition of platelet cyclic 3',5'-adenosine-monophosphate phosphodiesterases by pentifylline Arzneimittel-Forschung 25(5): 740-741
Gupta, G.S.; Singh, G. 1988: Catalytic properties and immunoprecipitation of beta-glucuronidase in presence of its IgG and Fab fragments: identification of antigenic domains Indian Journal of Biochemistry and Biophysics 25(4): 319-325
Wang, Y.; Pallen, C.J. 1991: The receptor-like protein tyrosine phosphatase HPTP alpha has two active catalytic domains with distinct substrate specificities EMBO Journal 10(11): 3231-3237
Fiedel, B.A.; Simpson, R.M.; Gewurz, H. 1977: Effects of C-reactive protein on platelet function. III. the role of cAMP, contractile elements, and prostaglandin metabolism in CRP-induced inhibition of platelet aggregation and secretion Journal of Immunology 119(3): 877-882
Dirks, W.; Nolte, M.; Werner, M.; Jäger, K.; Koch, C.; Drexler, H.G. 1996: Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma Leukemia 10(1): 150-158
Popov, K.M.; Bilargina, T.V.; Severin, E.S. 1985: Heterologous desensitization of pigeon erythrocyte adenylate cyclase by the catalytic subunit of cAMP-dependent protein kinase Biokhimiia 50(3): 443-446
Kochetkov, S.N.; Gabibov, A.G.; Mar'iash, L.I.; Shibnev, V.A.; Severin, E.S. 1984: Mechanism of action of cAMP-dependent protein kinase. IV. Interaction of the enzyme catalytic subunit with structural analogs of histone H1 Molekuliarnaia Biologiia 18(4): 901-906
Popov, K.M.; Bulargina, T.V.; Severin, E.S. 1985: Functional changes in the properties of beta-adrenoreceptors of pigeon erythrocytes after treatment with a catalytic subunit of cAMP-dependent protein kinase Biokhimiia 50(9): 1535-1538
Coyne, K.E.; Hall, S.E.; Thompson, S.; Arce, M.A.; Kinoshita, T.; Fujita, T.; Anstee, D.J.; Rosse, W.; Lublin, D.M. 1992: Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor Journal of Immunology 149(9): 2906-2913
Suga, K.; Nishigauchi, K.; Kume, N.; Kishimoto, K.; Matsunaga, N.; Fujioka, K.; Zempo, N.; Kensuke, E. 1998: The effects of new platelet inhibitory drug E-5510 on platelet deposition on aortic bifurcation grafts: assessment by indium-111-oxime labeled platelet imaging Clinical Nuclear Medicine 23(6): 365-369
Zang, C.-x.; Bao, X.-q.; Sun, H.; Zhang, D. 2016: The role of neuroinflammation-related regulatory targets in the treatment for Parkinson's disease Yao Xue Xue Bao 51(5): 677-683
Eshba, I.R.; Kochanova, N.A.; Popov, K.M.; Bulargina, T.V.; Severin, E.S. 1987: Use of monoclonal antibodies for purifying the regulatory subunit of cAMP-dependent protein kinase Biulleten' Eksperimental'noi Biologii i Meditsiny 103(5): 567-569
Mor, F.; Reizis, B.; Cohen, I.R.; Steinman, L. 1996: IL-2 and TNF receptors as targets of regulatory T-T interactions: isolation and characterization of cytokine receptor-reactive T cell lines in the Lewis rat Journal of Immunology 157(11): 4855-4861
Scheen, A.J. 1998: Drug clinics. how i treat various metabolic diseases treated by a drug intervention that targets the intestine Revue Medicale de Liege 53(11): 646-650
Zhao, Y.-m. 2010: Targets and principles for system design of quality control in clinical trials Zhonghua Yi Xue Za Zhi 90(26): 1801-1803
Williamson, D.; Giuliano, S.; Jackson, S.P. 1999: Platelet adhesion receptors: novel targets for anti-thrombotic therapy Australian and New Zealand Journal of Medicine 29(3): 452-461